Clinical trial
Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects
NCT00414778 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00414778 |
|---|---|
| Title | Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects |
| Official title | A Single-center, Open-label, Single and Multiple Oral Dose Study to Assess Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | LHT344 |
| Enrollment | 12 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2006 |
| First posted | Dec 22, 2006 |
| Last update posted | Jan 13, 2011 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: